Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer
NCT04348643 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2023-04-18
Summary
This is a single arm study to evaluate the efficacy and safety of CEA-targeted CAR-T cells therapy for patients with relapsed/refractory CEA+ Cancer,and obtain the recommended dose and infusion plan.
Conditions
Interventions
- BIOLOGICAL
-
CEA CAR-T cells
CEA-CAR-T cells will be administered intravenously.
Sponsors & Collaborators
-
Chongqing Precision Biotech Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-20
- Primary Completion
- 2023-12-31
- Completion
- 2024-04-30
Countries
- China
Study Locations
More Related Trials
-
A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)
NCT04513431 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases
NCT07247396 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
NCT03013712 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
NCT05240950 ·Status: RECRUITING ·Phase: PHASE1
-
CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
NCT02617134 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
EGFR CART Cells for Patients With Metastatic Colorectal Cancer
NCT03152435 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer
NCT03427684 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer
NCT03542799 ·Status: UNKNOWN ·Phase: PHASE1
-
NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer
NCT05248048 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Study on the Safety and Preliminary Efficacy of CDH17/GUCY2C CAR-T in the Treatment of Patients With Advanced Colorectal Cancer
NCT07152210 ·Status: RECRUITING ·Phase: NA
-
Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer
NCT06946615 ·Status: RECRUITING ·Phase: PHASE1
-
Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer
NCT06432075 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Neoadjuvant PDT in the Treatment of Cholangiocarcinoma
NCT04824742 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
NCT06848465 ·Status: RECRUITING ·Phase: PHASE1
-
Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer
NCT02423226 ·Status: COMPLETED ·Phase: PHASE2
-
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
NCT06104241 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer
NCT04333927 ·Status: UNKNOWN ·Phase: PHASE2
-
Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients
NCT05634694 ·Status: UNKNOWN
-
Preoperative Intraarterial Chemoembolization Combined With Radiotherpy in Locally Advanced Rectal Cancer
NCT03601156 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms
NCT05287165 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer
NCT05420584 ·Status: RECRUITING ·Phase: PHASE2
-
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
NCT06645301 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer
NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
BGT007H Cells for the Treatment of Refractory Digestive System Tumors
NCT06104215 ·Status: RECRUITING ·Phase: EARLY_PHASE1